NF‐κB promotes iNOS and VEGF expression in salivary gland adenoid cystic carcinoma cells and enhances endothelial cell motility in vitro
Authors:
- 13 March 2009
- journal article
- Published by Wiley in Cell Proliferation
- Vol. 42 (2) , 150-161
Abstract
Tumour cell‐derived angiogenic‐related factors and endothelial cell mobility are essential for neovascularization and haematogenous metastasis of adenoid cystic carcinoma (ACC) of the human salivary glands. Our previous study demonstrated that vascular endothelial growth factor (VEGF), inducible nitric oxide synthase (iNOS), and nuclear factor kappaB (NF‐κB) staining correlated with ACC microvessel density. However, there still remains a lack of direct evidence to clarify the function of liposaccharide‐induced NF‐κB activity in ACC angiogenesis.Objectives: This study aimed to demonstrate the function of liposaccharide‐induced NF‐κB signalling pathway (which would be relevant to angiogenesis) of ACC cell lines.Materials and methods: A PCMV‐IκBαM vector transfection assay was performed to inhibit NF‐κB activity. Constitutive and liposaccharide‐induced NF‐κB activity, along with VEGF and iNOS expression, was detected by electrophoretic mobility shift assays, reverse transcription–polymerase chain reaction and Western blot assay. Tumour cell‐derived NO2− was evaluated by a nitrite determination assay, and endothelial cell mobility was investigated by endothelial cell proliferation, migration and tube formation assays.Results: We demonstrated that regulation of VEGF and iNOS expression utilized the NF‐κB signalling pathway in ACC cell lines. In the constitutive and liposaccharide‐induced condition, NF‐κB activity was blocked by phosphorylation‐defective IκBα. Accordingly, mRNA and protein expression of VEGF and iNOS were significantly decreased, with a great drop in endogenous NO2−. Furthermore, supernatant from ACC‐2/IkBaM and ACC‐M/IkBaM cells resulted in much lower endothelial cell mobility than that from ACC‐2 and ACC‐M cells.Conclusions: Our results suggest that NF‐κB promotes iNOS and VEGF expression in salivary gland ACC cells and enhances endothelial cell motility in vitro.Keywords
This publication has 40 references indexed in Scilit:
- Hypoxia Inducible Factor-1–Independent Pathways in Tumor AngiogenesisClinical Cancer Research, 2007
- Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple MyelomaCancer Cell, 2007
- In vitro angiogenesis and expression of nuclear factor κB and VEGF in high and low metastasis cell lines of salivary gland Adenoid Cystic CarcinomaBMC Cancer, 2007
- The Inflammatory Cytokine Tumor Necrosis Factor-α Generates an Autocrine Tumor-Promoting Network in Epithelial Ovarian Cancer CellsCancer Research, 2007
- Nuclear factor-κB in cancer development and progressionNature, 2006
- Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancerCancer Letters, 2005
- The biology of VEGF and its receptorsNature Medicine, 2003
- Angiogenesis induced by advanced glycation end products and its prevention by cerivastatinThe FASEB Journal, 2002
- Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cellsOncogene, 1997
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996